{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:51:24Z","timestamp":1761540684440},"reference-count":47,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.canlet.2006.01.007","type":"journal-article","created":{"date-parts":[[2006,3,4]],"date-time":"2006-03-04T12:24:18Z","timestamp":1141475058000},"page":"195-204","source":"Crossref","is-referenced-by-count":8,"title":["Characterization of a clonal isolate of an oxaliplatin resistant ovarian carcinoma cell line A2780\/C10"],"prefix":"10.1016","volume":"245","author":[{"given":"Suzanne","family":"Hector","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Enriqueta","family":"Nava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmi","family":"Pendyala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.canlet.2006.01.007_bib1","first-page":"5970","article-title":"In vitro cytotoxicity, protein binding, red blood cell partitioning, and biotransformation of oxaliplatin","volume":"53","author":"Pendyala","year":"1993","journal-title":"Cancer Research"},{"issue":"2 Suppl 5","key":"10.1016\/j.canlet.2006.01.007_bib2","first-page":"4","article-title":"Oxaliplatin: mechanism of action and antineoplastic activity","volume":"25","author":"Raymond","year":"1998","journal-title":"Seminars in Oncology"},{"issue":"12","key":"10.1016\/j.canlet.2006.01.007_bib3","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0006-2952(97)81490-6","article-title":"Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel","volume":"52","author":"Rixe","year":"1996","journal-title":"Biochemical Pharmacology"},{"issue":"10","key":"10.1016\/j.canlet.2006.01.007_bib4","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/oxfordjournals.annonc.a010500","article-title":"Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer","volume":"7","author":"Chollet","year":"1996","journal-title":"Annals of Oncology"},{"issue":"5","key":"10.1016\/j.canlet.2006.01.007_bib5","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1124\/mol.54.5.770","article-title":"Sequence- and region-specificity of oxaliplatin adducts in naked and cellular DNA","volume":"54","author":"Woynarowski","year":"1998","journal-title":"Molecular Pharmacology"},{"issue":"5","key":"10.1016\/j.canlet.2006.01.007_bib6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s002800100363","article-title":"In vitro studies on the mechanisms of oxaliplatin resistance","volume":"48","author":"Hector","year":"2001","journal-title":"Cancer Chemotherapy Pharmacology"},{"issue":"12","key":"10.1016\/j.canlet.2006.01.007_bib7","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1093\/carcin\/17.12.2763","article-title":"In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells","volume":"17","author":"Saris","year":"1996","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.canlet.2006.01.007_bib8","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1124\/mol.58.5.920","article-title":"Oxaliplatin-induced damage of cellular DNA","volume":"58","author":"Woynarowski","year":"2000","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.canlet.2006.01.007_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-1-4615-2632-2_11","article-title":"Mechanisms of acquired resistance to cisplatin","volume":"73","author":"Andrews","year":"1994","journal-title":"Cancer Treatment and Research"},{"issue":"1","key":"10.1016\/j.canlet.2006.01.007_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/j.1875-9114.1996.tb02913.x","article-title":"Insights into mechanisms of cisplatin resistance and potential for its clinical reversal [Review]","volume":"16","author":"Gosland","year":"1996","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.canlet.2006.01.007_bib11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0021-9258(17)42175-2","article-title":"Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair [Review]","volume":"269","author":"Chu","year":"1994","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/j.canlet.2006.01.007_bib12","first-page":"850","article-title":"Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines","volume":"57","author":"Johnson","year":"1997","journal-title":"Cancer Research"},{"key":"10.1016\/j.canlet.2006.01.007_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1023\/A:1008016922425","article-title":"Nucleotide excision repair and anti-cancer chemotherapy","volume":"27","author":"Reed","year":"1998","journal-title":"Cytotechnology"},{"key":"10.1016\/j.canlet.2006.01.007_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev.bi.65.070196.000355","article-title":"DNA excision repair","volume":"65","author":"Sancar","year":"1997","journal-title":"Annual Review of Biochemistry"},{"key":"10.1016\/j.canlet.2006.01.007_bib15","doi-asserted-by":"crossref","first-page":"15915","DOI":"10.1074\/jbc.270.27.15915","article-title":"Excision repair in mammalian cells","volume":"270","author":"Sancar","year":"1995","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.canlet.2006.01.007_bib16","first-page":"4124","article-title":"A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation","volume":"56","author":"Taniguchi","year":"1996","journal-title":"Cancer Research"},{"issue":"1","key":"10.1016\/j.canlet.2006.01.007_bib17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1523-1747.2003.12313.x","article-title":"Overexpression of cMOAT (MRP2\/ABCC2) is associated with decreased formation of platinum-DNA adducts and decreased G2-arrest in melanoma cells resistant to cisplatin","volume":"121","author":"Liedert","year":"2003","journal-title":"Journal of Investigative Dermatology"},{"issue":"21","key":"10.1016\/j.canlet.2006.01.007_bib18","first-page":"4881","article-title":"The role of DNA mismatch repair in platinum drug resistance","volume":"56","author":"Fink","year":"1996","journal-title":"Cancer Research"},{"issue":"10","key":"10.1016\/j.canlet.2006.01.007_bib19","first-page":"1841","article-title":"In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair","volume":"57","author":"Fink","year":"1997","journal-title":"Cancer Research"},{"issue":"13","key":"10.1016\/j.canlet.2006.01.007_bib20","first-page":"3500","article-title":"Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines","volume":"54","author":"Mamenta","year":"1994","journal-title":"Cancer Research"},{"issue":"16","key":"10.1016\/j.canlet.2006.01.007_bib21","first-page":"3579","article-title":"The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum\u2013DNA adducts","volume":"58","author":"Vaisman","year":"1998","journal-title":"Cancer Research"},{"issue":"10","key":"10.1016\/j.canlet.2006.01.007_bib22","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0959-8049(02)00096-5","article-title":"The cellular pharmacology of oxaliplatin resistance","volume":"38","author":"Mishima","year":"2002","journal-title":"European Journal of Cancer"},{"issue":"10\u201311","key":"10.1016\/j.canlet.2006.01.007_bib23","first-page":"415","article-title":"Induction of gamma-glutamyl transpeptidase mRNA by platinum complexes in a human ovarian carcinoma cell line","volume":"8","author":"El-akawi","year":"1996","journal-title":"Oncology Research"},{"issue":"1","key":"10.1016\/j.canlet.2006.01.007_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3835(96)04245-0","article-title":"Altered glutathione metabolism in oxaliplatin resistant ovarian carcinoma cells","volume":"105","author":"El-akawi","year":"1996","journal-title":"Cancer Letters"},{"issue":"1","key":"10.1016\/j.canlet.2006.01.007_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00280-004-0819-9","article-title":"cDNA microarray-based identification of genes and pathways associated with oxaliplatin resistance","volume":"55","author":"Samimi","year":"2005","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"10.1016\/j.canlet.2006.01.007_bib26","first-page":"925","article-title":"Gene expression profiling of a clonal isolate of oxaliplatin resistant A2780 ovarian carcinoma cell line A2780\/C10","volume":"14","author":"Varma","year":"2005","journal-title":"Oncology Reports"},{"key":"10.1016\/j.canlet.2006.01.007_bib27","series-title":"Isolation and Preliminary Characterization of Oxaliplatin Resistant Sublines of A2780 Human Ovarian Carcinoma Cell Line","author":"Glavy","year":"1993"},{"issue":"13","key":"10.1016\/j.canlet.2006.01.007_bib28","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/jnci\/82.13.1113","article-title":"Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines","volume":"82","author":"Rubinstein","year":"1990","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.canlet.2006.01.007_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0076-6879(87)43016-4","article-title":"Determination of low-molecular-weight thiols using monobromobimane fluorescent labeling and high-performance liquid chromatography","volume":"143","author":"Fahey","year":"1987","journal-title":"Methods in Enzymology"},{"issue":"1","key":"10.1016\/j.canlet.2006.01.007_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-200038010-00001","article-title":"Oxaliplatin: pharmacokinetics and chronopharmacological aspects [Review]","volume":"38","author":"Levi","year":"2000","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.canlet.2006.01.007_bib31","first-page":"542","article-title":"Pharmokinetic Modeling of oxalipaltin with and without 5-FU and radiation","volume":"42","author":"Smith","year":"2002","journal-title":"Proceedings of the American Association for Cancer Research"},{"issue":"11\u201312","key":"10.1016\/j.canlet.2006.01.007_bib32","first-page":"595","article-title":"Cytotoxicity, cellular uptake, and cellular biotransformations of oxaliplatin in human colon carcinoma cells","volume":"10","author":"Luo","year":"1998","journal-title":"Oncology Research"},{"issue":"2","key":"10.1016\/j.canlet.2006.01.007_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0304-3835(95)03974-2","article-title":"Cytotoxicity, cellular accumulation and DNA binding of oxaliplatin isomers","volume":"97","author":"Pendyala","year":"1995","journal-title":"Cancer Letters"},{"key":"10.1016\/j.canlet.2006.01.007_bib34","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI200320530","article-title":"Epithelial\u2013mesenchymal transition and its implications for fibrosis","volume":"112","author":"Kalluri","year":"2003","journal-title":"Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/j.canlet.2006.01.007_bib35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1586\/14737140.2.4.449","article-title":"Integrins and extracellular matrix: a novel mechanism of multidrug resistance [Review]","volume":"2","author":"Elliott","year":"2002","journal-title":"Expert Review of Anticancer Therapy"},{"issue":"7","key":"10.1016\/j.canlet.2006.01.007_bib36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1158\/1535-7163.813.3.7","article-title":"Polyamine catabolism in platinum drug action: Interactions between oxaliplatin and the polyamine analogue N\u2032,N\u2033-diethylnorspermine at the level of spermidine\/spermine N\u2032-acetyltransferase","volume":"3","author":"Hector","year":"2004","journal-title":"Molecular Cancer Therapeutics"},{"issue":"3","key":"10.1016\/j.canlet.2006.01.007_bib37","first-page":"227","article-title":"Cellular and molecular pharmacology of oxaliplatin","volume":"1","author":"Raymond","year":"2002","journal-title":"Molecular Cancer Therapeutics"},{"issue":"3","key":"10.1016\/j.canlet.2006.01.007_bib38","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1124\/mol.56.3.633","article-title":"Molecular modeling of the intrastrand guanine\u2013guanine DNA adducts produced by cisplatin and oxaliplatin","volume":"56","author":"Scheeff","year":"1999","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.canlet.2006.01.007_bib39","first-page":"1383","article-title":"Spermidine\/spermine N\u2032-acetyltransferase as a determinant of oxaliplatin drug action and resistance","volume":"46","author":"Hector","year":"2005","journal-title":"Proceedings of the American Association for Cancer Research"},{"issue":"10","key":"10.1016\/j.canlet.2006.01.007_bib40","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.jinorgbio.2004.05.006","article-title":"The role of copper transporters in the development of resistance to Pt drugs [Review]","volume":"98","author":"Safaei","year":"2004","journal-title":"Journal of Inorganic Biochemistry"},{"issue":"14","key":"10.1016\/j.canlet.2006.01.007_bib41","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1158\/1078-0432.CCR-04-0137","article-title":"Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells","volume":"10","author":"Samimi","year":"2004","journal-title":"Clinical Cancer Research"},{"issue":"4","key":"10.1016\/j.canlet.2006.01.007_bib42","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1535-6108(03)00058-8","article-title":"Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells","volume":"3","author":"Sherman-Baust","year":"2003","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.canlet.2006.01.007_bib43","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1470-2045(00)00421-6","article-title":"The role of extracellular matrix in small-cell lung cancer [Review]","volume":"2","author":"Rintoul","year":"2001","journal-title":"Lancet Oncology"},{"issue":"6","key":"10.1016\/j.canlet.2006.01.007_bib44","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/9511","article-title":"Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo","volume":"5","author":"Sethi","year":"1999","journal-title":"Nature Medicine"},{"issue":"4","key":"10.1016\/j.canlet.2006.01.007_bib45","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/CS20010216","article-title":"Extracellular matrix regulation of drug resistance in small-cell lung cancer [Review]","volume":"102","author":"Rintoul","year":"2002","journal-title":"Clinical Science"},{"key":"10.1016\/j.canlet.2006.01.007_bib46","first-page":"878","article-title":"Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy","volume":"8","author":"Tannock","year":"2002","journal-title":"Clinical Cancer Research"},{"issue":"4","key":"10.1016\/j.canlet.2006.01.007_bib47","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0006-2952(94)90132-5","article-title":"Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines","volume":"47","author":"Johnson","year":"1994","journal-title":"Biochemical Pharmacology"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383506000292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383506000292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T05:50:07Z","timestamp":1706939407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383506000292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":47,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0304383506000292"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2006.01.007","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}